Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...
Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...
Guardant Health, Inc., a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening is now covered for active-duty service members and their families ...
NEW YORK, Oct. 28 (UPI) --New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many people choose this alternative, a new study ...
WASHINGTON (DC News Now) — A new blood test may make it much easier and cheaper to screen for signs of colon cancer. Test manufacturer Guardant said the Food and Drug Administration (FDA) approved its ...
SAN DIEGO — In the ever-expanding options for colorectal cancer (CRC) screening, blood tests using precision medicine are becoming more advanced and convenient than ever; however, caveats abound, and ...
(a) “You don’t have to worry about that. Colon cancer is mainly a man’s disease.” (b) “Yes, everyone should have a colonoscopy every year to check for colon cancer.” (c) “I’ll do a rectal exam today, ...
(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...
Colorectal cancer (CRC) is a major public health issue, with over 43,000 new cases and nearly 17,700 deaths annually in France. The overall survival rate is currently 63%. It is much higher for early ...
Studies using the three-card, take-home method of FOBT screening repeated over a number of years have demonstrated mortality reductions of up to 33%. Conversely, there are no large studies documenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results